Does the media favor ICLR or CRL?

In the previous week, Charles River Laboratories International had 8 more articles in the media than Icon. MarketBeat recorded 11 mentions for Charles River Laboratories International and 3 mentions for Icon. Icon's average media sentiment score of 1.00 beat Charles River Laboratories International's score of 0.91 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Charles River Laboratories International 5 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend IQV or ICLR?

IQVIA currently has a consensus price target of $264.31, suggesting a potential upside of 2.61%. Icon has a consensus price target of $172.40, suggesting a potential upside of 6.92%. Given Icon's higher probable upside, analysts plainly believe Icon is more favorable than IQVIA. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IQVIA 0 Sell rating(s) 3 Hold rating(s) 12 Buy rating(s) 2 Strong Buy rating(s) 2.94 Icon 2 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.39

Which has preferable earnings and valuation, IQV or ICLR?

IQVIA has higher revenue and earnings than Icon. IQVIA is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IQVIA $16.31B 2.60 $1.36B $8.06 31.96 Icon $8.25B 1.50 $229.34M $4.26 37.85

Is IQV or ICLR more profitable?

IQVIA has a net margin of 8.10% compared to Icon's net margin of 3.99%. IQVIA's return on equity of 30.25% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets IQVIA 8.10% 30.25% 6.54% Icon 3.99% 8.02% 4.56%

Does the media favor IQV or ICLR?

In the previous week, IQVIA had 8 more articles in the media than Icon. MarketBeat recorded 11 mentions for IQVIA and 3 mentions for Icon. Icon's average media sentiment score of 1.00 beat IQVIA's score of 0.45 indicating that Icon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IQVIA 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Icon 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ICLR or A?

In the previous week, Agilent Technologies had 9 more articles in the media than Icon. MarketBeat recorded 12 mentions for Agilent Technologies and 3 mentions for Icon. Icon's average media sentiment score of 1.00 beat Agilent Technologies' score of 0.29 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 2 Very Positive mention(s) 0 Positive mention(s) 10 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, ICLR or WAT?

Waters has lower revenue, but higher earnings than Icon. Icon is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Icon $8.25B 1.50 $229.34M $4.26 37.85 Waters $3.17B 13.20 $642.63M $4.01 106.04

Is ICLR or WAT more profitable?

Icon has a net margin of 3.99% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Icon 3.99% 8.02% 4.56% Waters 3.58% 11.27% 6.73%

Does the media prefer ICLR or WAT?

In the previous week, Waters had 10 more articles in the media than Icon. MarketBeat recorded 13 mentions for Waters and 3 mentions for Icon. Icon's average media sentiment score of 1.00 beat Waters' score of 0.18 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Waters 3 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, ICLR or ILMN?

Illumina has lower revenue, but higher earnings than Icon. Icon is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Icon $8.25B 1.50 $229.34M $4.26 37.85 Illumina $4.34B 9.32 $850M $5.36 50.01

Is ICLR or ILMN more profitable?

Illumina has a net margin of 18.36% compared to Icon's net margin of 3.99%. Illumina's return on equity of 29.84% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Icon 3.99% 8.02% 4.56% Illumina 18.36% 29.84% 12.17%

Does the media prefer ICLR or ILMN?

In the previous week, Illumina had 5 more articles in the media than Icon. MarketBeat recorded 8 mentions for Illumina and 3 mentions for Icon. Icon's average media sentiment score of 1.00 beat Illumina's score of 0.42 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Icon (ICLR) Competitors

$162.05 +0.20 (+0.12%)

Closing price 04:00 PM Eastern

Extended Trading

$161.96 -0.09 (-0.06%)

As of 04:10 PM Eastern

Compare

ICLR vs. CRL, IQV, A, WAT, and ILMN

Should you buy Icon stock or one of its competitors? Icon's main competitors and comparable companies include Charles River Laboratories International (CRL), IQVIA (IQV), Agilent Technologies (A), Waters (WAT), and Illumina (ILMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Icon compare to Charles River Laboratories International?

Icon (NASDAQ:ICLR) and Charles River Laboratories International (NYSE:CRL) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Icon has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Icon	$8.25B	1.50	$229.34M	$4.26	37.85
Charles River Laboratories International	$4.02B	3.42	-$144.34M	-$4.85	N/A

In the previous week, Charles River Laboratories International had 8 more articles in the media than Icon. MarketBeat recorded 11 mentions for Charles River Laboratories International and 3 mentions for Icon. Icon's average media sentiment score of 1.00 beat Charles River Laboratories International's score of 0.91 indicating that Icon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Icon	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Charles River Laboratories International	5 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Icon presently has a consensus target price of $172.40, suggesting a potential upside of 6.92%. Charles River Laboratories International has a consensus target price of $300.11, suggesting a potential upside of 4.32%. Given Icon's higher possible upside, equities research analysts plainly believe Icon is more favorable than Charles River Laboratories International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Icon	2 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.39
Charles River Laboratories International	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.82

Icon has a net margin of 3.99% compared to Charles River Laboratories International's net margin of -5.96%. Charles River Laboratories International's return on equity of 15.75% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Icon	3.99%	8.02%	4.56%
Charles River Laboratories International	-5.96%	15.75%	6.51%

Icon has a beta of 1.24, indicating that its stock price is 24% more volatile than the broader market. Comparatively, Charles River Laboratories International has a beta of 1.4, indicating that its stock price is 40% more volatile than the broader market.

95.6% of Icon shares are owned by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are owned by institutional investors. 44.0% of Icon shares are owned by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Icon and Charles River Laboratories International tied by winning 8 of the 16 factors compared between the two stocks.

How does Icon compare to IQVIA?

IQVIA (NYSE:IQV) and Icon (NASDAQ:ICLR) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment.

IQVIA has higher revenue and earnings than Icon. IQVIA is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$16.31B	2.60	$1.36B	$8.06	31.96
Icon	$8.25B	1.50	$229.34M	$4.26	37.85

IQVIA has a beta of 1.17, indicating that its share price is 17% more volatile than the broader market. Comparatively, Icon has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market.

89.6% of IQVIA shares are held by institutional investors. Comparatively, 95.6% of Icon shares are held by institutional investors. 1.7% of IQVIA shares are held by insiders. Comparatively, 44.0% of Icon shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

IQVIA currently has a consensus price target of $264.31, suggesting a potential upside of 2.61%. Icon has a consensus price target of $172.40, suggesting a potential upside of 6.92%. Given Icon's higher probable upside, analysts plainly believe Icon is more favorable than IQVIA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Icon	2 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.39

In the previous week, IQVIA had 8 more articles in the media than Icon. MarketBeat recorded 11 mentions for IQVIA and 3 mentions for Icon. Icon's average media sentiment score of 1.00 beat IQVIA's score of 0.45 indicating that Icon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IQVIA	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Icon	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IQVIA has a net margin of 8.10% compared to Icon's net margin of 3.99%. IQVIA's return on equity of 30.25% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	8.10%	30.25%	6.54%
Icon	3.99%	8.02%	4.56%

Summary

IQVIA beats Icon on 11 of the 17 factors compared between the two stocks.

How does Icon compare to Agilent Technologies?

Icon (NASDAQ:ICLR) and Agilent Technologies (NYSE:A) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, earnings, risk and valuation.

Icon has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market. Comparatively, Agilent Technologies has a beta of 1.2, suggesting that its share price is 20% more volatile than the broader market.

95.6% of Icon shares are owned by institutional investors. 44.0% of Icon shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Agilent Technologies had 9 more articles in the media than Icon. MarketBeat recorded 12 mentions for Agilent Technologies and 3 mentions for Icon. Icon's average media sentiment score of 1.00 beat Agilent Technologies' score of 0.29 indicating that Icon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Icon	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agilent Technologies	2 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Agilent Technologies has lower revenue, but higher earnings than Icon. Agilent Technologies is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Icon	$8.25B	1.50	$229.34M	$4.26	37.85
Agilent Technologies	$6.95B	6.80	$1.30B	$5.08	32.97

Icon currently has a consensus target price of $172.40, indicating a potential upside of 6.92%. Agilent Technologies has a consensus target price of $170.33, indicating a potential upside of 1.69%. Given Icon's higher probable upside, analysts plainly believe Icon is more favorable than Agilent Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Icon	2 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.39
Agilent Technologies	0 Sell rating(s)	5 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.80

Agilent Technologies has a net margin of 19.53% compared to Icon's net margin of 3.99%. Agilent Technologies' return on equity of 24.45% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Icon	3.99%	8.02%	4.56%
Agilent Technologies	19.53%	24.45%	13.09%

Summary

Agilent Technologies beats Icon on 9 of the 16 factors compared between the two stocks.

How does Icon compare to Waters?

Icon (NASDAQ:ICLR) and Waters (NYSE:WAT) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

Icon currently has a consensus price target of $172.40, suggesting a potential upside of 6.92%. Waters has a consensus price target of $437.10, suggesting a potential upside of 2.79%. Given Icon's higher possible upside, equities analysts clearly believe Icon is more favorable than Waters.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Icon	2 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.39
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85

In the previous week, Waters had 10 more articles in the media than Icon. MarketBeat recorded 13 mentions for Waters and 3 mentions for Icon. Icon's average media sentiment score of 1.00 beat Waters' score of 0.18 indicating that Icon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Icon	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Waters	3 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Icon has a net margin of 3.99% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Icon	3.99%	8.02%	4.56%
Waters	3.58%	11.27%	6.73%

95.6% of Icon shares are held by institutional investors. Comparatively, 94.0% of Waters shares are held by institutional investors. 44.0% of Icon shares are held by insiders. Comparatively, 0.3% of Waters shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Icon has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market. Comparatively, Waters has a beta of 1.15, meaning that its stock price is 15% more volatile than the broader market.

Waters has lower revenue, but higher earnings than Icon. Icon is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Icon	$8.25B	1.50	$229.34M	$4.26	37.85
Waters	$3.17B	13.20	$642.63M	$4.01	106.04

Summary

Waters beats Icon on 9 of the 17 factors compared between the two stocks.

How does Icon compare to Illumina?

Icon (NASDAQ:ICLR) and Illumina (NASDAQ:ILMN) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

Illumina has lower revenue, but higher earnings than Icon. Icon is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Icon	$8.25B	1.50	$229.34M	$4.26	37.85
Illumina	$4.34B	9.32	$850M	$5.36	50.01

In the previous week, Illumina had 5 more articles in the media than Icon. MarketBeat recorded 8 mentions for Illumina and 3 mentions for Icon. Icon's average media sentiment score of 1.00 beat Illumina's score of 0.42 indicating that Icon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Icon	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Illumina	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Illumina has a net margin of 18.36% compared to Icon's net margin of 3.99%. Illumina's return on equity of 29.84% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Icon	3.99%	8.02%	4.56%
Illumina	18.36%	29.84%	12.17%

Icon has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market. Comparatively, Illumina has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market.

Icon currently has a consensus target price of $172.40, indicating a potential upside of 6.92%. Illumina has a consensus target price of $214.69, indicating a potential downside of 19.91%. Given Icon's higher possible upside, analysts clearly believe Icon is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Icon	2 Sell rating(s)	8 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.39
Illumina	2 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.44

95.6% of Icon shares are held by institutional investors. Comparatively, 89.4% of Illumina shares are held by institutional investors. 44.0% of Icon shares are held by insiders. Comparatively, 2.9% of Illumina shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Illumina beats Icon on 11 of the 17 factors compared between the two stocks.

Get Icon News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ICLR vs. The Competition

Export

Metric	Icon	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$12.41B	$10.65B	$7.10B	$13.24B
Dividend Yield	N/A	1.45%	2.53%	15.88%
P/E Ratio	38.04	74.99	274.33	26.05
Price / Sales	1.50	108.61	601.06	89.40
Price / Cash	10.09	27.76	77.38	51.25
Price / Book	1.35	6.85	10.92	6.31
Net Income	$229.34M	$57.48B	$3.50B	$361.43M
7 Day Performance	-5.97%	2.61%	-2.11%	-1.67%
1 Month Performance	1.38%	7.66%	-6.34%	-3.94%
1 Year Performance	-16.02%	35.50%	8.81%	2.77%

Icon Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ICLR Icon	3.3765 of 5 stars	$162.05 +0.1%	$172.40 +6.4%	-15.8%	$12.41B	$8.25B	38.04	40,100	Positive News Analyst Upgrade
CRL Charles River Laboratories International	3.6208 of 5 stars	$279.70 +0.6%	$273.81 -2.1%	+68.1%	$13.27B	$4.02B	N/A	19,700	Analyst Upgrade
IQV IQVIA	3.2784 of 5 stars	$270.69 +1.6%	$248.00 -8.4%	+27.7%	$43.85B	$16.31B	33.58	93,000	Analyst Forecast
A Agilent Technologies	4.2403 of 5 stars	$162.06 +3.6%	$170.33 +5.1%	+19.9%	$44.11B	$6.95B	31.90	18,100
WAT Waters	2.5037 of 5 stars	$424.33 +0.6%	$434.60 +2.4%	+33.0%	$41.42B	$3.17B	105.82	7,900	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ICLR) was last updated on 10/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Icon (ICLR) Competitors

ICLR vs. CRL, IQV, A, WAT, and ILMN

How does Icon compare to Charles River Laboratories International?

Summary

How does Icon compare to IQVIA?

Summary

How does Icon compare to Agilent Technologies?

Summary

How does Icon compare to Waters?

Summary

How does Icon compare to Illumina?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICLR vs. The Competition

Icon Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Icon (ICLR) Competitors

ICLR vs. CRL, IQV, A, WAT, and ILMN

How does Icon compare to Charles River Laboratories International?

Which has preferable earnings and valuation, ICLR or CRL?

Does the media favor ICLR or CRL?

Do analysts rate ICLR or CRL?

Is ICLR or CRL more profitable?

Which has more volatility & risk, ICLR or CRL?

Do institutionals and insiders hold more shares of ICLR or CRL?

Summary

How does Icon compare to IQVIA?

Which has preferable earnings and valuation, IQV or ICLR?

Which has more volatility & risk, IQV or ICLR?

Do institutionals and insiders have more ownership in IQV or ICLR?

Do analysts recommend IQV or ICLR?

Does the media favor IQV or ICLR?

Is IQV or ICLR more profitable?

Summary

How does Icon compare to Agilent Technologies?

Which has more volatility & risk, ICLR or A?

Do institutionals and insiders believe in ICLR or A?

Does the media prefer ICLR or A?

Which has stronger earnings & valuation, ICLR or A?

Do analysts prefer ICLR or A?

Is ICLR or A more profitable?

Summary

How does Icon compare to Waters?

Do analysts rate ICLR or WAT?

Does the media prefer ICLR or WAT?

Is ICLR or WAT more profitable?

Do institutionals and insiders have more ownership in ICLR or WAT?

Which has more risk and volatility, ICLR or WAT?

Which has preferable valuation and earnings, ICLR or WAT?

Summary

How does Icon compare to Illumina?

Which has better valuation & earnings, ICLR or ILMN?

Does the media prefer ICLR or ILMN?

Is ICLR or ILMN more profitable?

Which has more risk and volatility, ICLR or ILMN?

Do analysts prefer ICLR or ILMN?

Do insiders and institutionals have more ownership in ICLR or ILMN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICLR vs. The Competition

Icon Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools